Tevogen Bio Holdings Inc. (TVGN) Key Metrics
TVGN valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $46.0M
- Enterprise value
- $68.0M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- —
- Price / book
- —
- EV / EBITDA
- 18.3
- Dividend yield
- —
- Beta
- 0.20
TVGN key metrics, FY2022–FY2026
Fiscal year ended June 30, 2026 · U.S. dollarsTVGN valuation Price multiples at each fiscal year-end price.
TVGN returns How much profit the business earns on the capital it uses.
TVGN per-share figures Results divided by the shares outstanding at year-end.
TVGN financial health Debt, liquidity and how easily interest is covered.
TVGN valuation history
TVGN returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
TVGN debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
TVGN cash returned to shareholders
TVGN price vs earnings per share
TVGN key metrics
FY2022–FY2026| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Valuation | |||||
| Market capitalization | $18.8M | $183.3M | $119.6M | $1.28B | — |
| Enterprise value | $21.3M | $184.9M | $214.0M | $1.32B | — |
| P/E ratio | — | — | — | 290.7 | — |
| EV / EBITDA | — | — | — | 283.7 | — |
| Earnings yield | −139.8% | −5.5% | −50.6% | 0.3% | — |
| Free cash flow yield | −66.0% | −6.5% | −6.9% | −0.7% | — |
| Shareholder yield (dividends + buybacks) | — | — | 286.8% | 0.0% | — |
| Share price at fiscal year-end | $5.66 | $62.50 | $36.15 | $534.00 | $500.50 |
| Per share | |||||
| Revenue per share | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Earnings per share | −$7.91 | −$3.45 | −$18.28 | $1.84 | — |
| Operating cash flow per share | −$3.71 | −$4.09 | −$2.47 | −$3.61 | — |
| Free cash flow per share | −$3.73 | −$4.09 | −$2.51 | −$3.81 | — |
| Cash per share | $0.17 | $0.44 | $0.32 | $2.29 | — |
| Book value per share | −$2.48 | −$2.28 | −$28.54 | −$14.15 | — |
| Tangible book value per share | −$2.48 | −$2.28 | −$28.54 | −$14.15 | — |
| Capex per share | $0.02 | $0.00 | $0.04 | $0.20 | — |
| Debt per share | $0.93 | $0.98 | $28.84 | $16.67 | — |
| Shares outstanding | 3.3M | 2.9M | 3.3M | 2.4M | — |
| Change in shares outstanding | +13.2% | −11.3% | +37.9% | — | — |
| Returns & profitability | |||||
| Return on invested capital (ROIC) | — | — | — | −429.6% | — |
| Return on assets (ROA) | −669.9% | −225.6% | −913.2% | 57.3% | −203.7% |
| Return on tangible assets | −599.5% | −292.2% | — | 57.0% | −203.7% |
| Income quality (OCF / net income) | — | — | — | −1.96 | — |
| Financial health | |||||
| Total debt | $3.1M | $2.9M | $95.4M | $40.0M | $23.5M |
| Cash & short-term investments | $552,372 | $1.3M | $1.1M | $5.5M | $7.1M |
| Net debt | $2.5M | $1.6M | $94.4M | $34.5M | $16.4M |
| Debt / assets | 0.71 | 0.83 | 17.33 | 5.17 | 3.07 |
| Net debt / EBITDA | — | — | — | 7.44 | — |
| Current ratio | 0.22 | 0.26 | 0.02 | 2.98 | 10.74 |
| Quick ratio | 0.22 | 0.26 | 0.02 | 2.98 | 10.74 |
| Interest coverage | -133.6 | -291.1 | -34.5 | — | -7.7 |
| Working capital | −$5.5M | −$6.7M | −$83.8M | $3.9M | $6.5M |
| Invested capital | −$5.7M | −$5.1M | −$61,722 | $572,451 | −$128,710 |
| Tangible asset value | −$8.2M | −$6.7M | −$94.4M | −$34.0M | −$16.5M |
| Net current asset value | −$11.1M | −$7.8M | −$98.2M | −$35.9M | −$17.0M |
| Graham net-net per share | −$3.60 | −$2.98 | −$29.81 | −$15.09 | — |
| Capital allocation | |||||
| Share buybacks (net) | — | — | $343.0M | $0 | — |
| Capex / depreciation | 0.13 | 0.00 | 0.35 | 2.08 | 11.70 |
| Efficiency | |||||
| Days payables outstanding | — | 3,897.4 | 2,066.5 | — | — |
| Receivables turnover | 0.00 | 0.00 | 0.00 | — | — |
| Payables turnover | — | 0.09 | 0.18 | — | — |
| Asset turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average receivables | $158,819 | $251,660 | $344,500 | — | — |
| Average payables | $4.3M | $4.3M | $2.1M | $621,954 | $377,997 |
| Intangibles / total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Computed from TVGN's annual financial statements (latest annual report filed March 31, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
TVGN valuation and financial ratios
It ended the year with $3.1 million of debt and $0.6 million in cash and short-term investments, net debt of $2.5 million.
See the TVGN income statement, the TVGN chart for price history, or the TVGN stock overview for the latest quote and news.
TVGN key metrics FAQ
How much debt does Tevogen Bio have?
Tevogen Bio had total debt of $3.1 million at the end of fiscal 2026.
What is Tevogen Bio's free cash flow yield?
Tevogen Bio generated -$12.4 million of free cash flow in fiscal 2026, a free cash flow yield of −66.0% on its market value at year-end ($18.8 million).
What is Tevogen Bio's current ratio?
Tevogen Bio's current ratio was 0.22 at the end of fiscal 2026: current assets were 0.22 times current liabilities.